GlassScriptLipiflow System Activator II (Disposable
Payments companies reported to CMS as associated with Lipiflow System Activator II (Disposable. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lipiflow System Activator II (Disposable, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lipiflow System Activator II (Disposable
These are the largest totals companies reported as associated with Lipiflow System Activator II (Disposable. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Katherine Chen | Irvine, CA | Ophthalmology | $524.60 |
| Anthony Mai | Sioux Falls, SD | Ophthalmology | $524.60 |
| Bryson Tudor | Grand Junction, CO | Ophthalmology | $524.60 |
| Grace Su | San Jose, CA | Ophthalmology | $524.60 |
| Mariana Abi Karam | Miami, FL | Pediatric Ophthalmology and Strabismus Specialist | $524.60 |
| Sahal Saleh | Edina, MN | Retina Specialist | $524.60 |
| Bohan Xing | Tucson, AZ | Ophthalmology | $524.60 |
| Alexi Geevarghese | San Diego, CA | Cornea and External Diseases Specialist | $262.30 |
| Jeremy Kieval | Lexington, MA | Ophthalmology | $262.30 |
| Brennan Boyd | Phoenix, AZ | Ophthalmology | $262.30 |
Prescribed Lipiflow System Activator II (Disposable?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.